I agree, the working capital is an indication of the final quarter sales. It could also be partly free doses provided to clinical trials and other countries.
I'm happy to leave these in the bottom drawer, expecting the market to resume bear mode but SRX should be left alone given the low liquidity.
sirtex has $21m cash, page-5
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $74.27M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 17.8¢ | 17.5¢ | $51.74K | 295.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 2529419 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 2426769 | 38 |
View Market Depth
| Last trade - 16.10pm 14/08/2024 (20 minute delay) ? |
| SRX (ASX) Chart |